Evidence mapPaperPMID 36677849Full record

ArticleMolecules (Basel, Switzerland)2023

Pharmacodynamics, Pharmacokinetics, and Kidney Distribution of Raw and Wine-Steamed Ligustri Lucidi Fructus Extracts in Diabetic Nephropathy Rats.

Ruqiao Luan, Pan Zhao, Xuelan Zhang, Qinqing Li, Xinfeng Chen, Ling Wang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Protective Effects ofAnimals : an open access journal from MDPI · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ruqiao LuanInnovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Pan ZhaoSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Xuelan ZhangSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Qinqing LiSchool of Pharmacy, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Xinfeng ChenSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Ling WangSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Shandong University of Traditional Chinese Medicine · CNShanxi University · CN

Funding

Shandong Provincial Collaborative Ivation Center Project for Quality Control and Construction of the Whole Industrial Chain of Traditional Chinese Medicine CYLXTCX2021-12the National Key Research and Development Program of China 2018YFC1707204the National Natural Science Foundation of China 81373968the National Natural Science Foundation of China 81973486the National Natural Science Foundation of China 82173974
6 · The paper itself

Abstract

The purpose of this study was to investigate differences in the pharmacodynamic, pharmacokinetic, and kidney distribution between Ligustri Lucidi Fructus (LLF) and wine-steamed Ligustri Lucidi Fructus (WLL) extracts in diabetic nephropathy (DN) rats. The DN rats were induced by high-fat-sugar diet (HFSD)/streptozotocin (STZ) regimen. For pharmacodynamics, the DN rats were treated with LLF and WLL extracts to assess the anti-diabetic nephropathy effects. For pharmacokinetics and kidney distribution, the concentrations of drugs (hydroxytyrosol, salidroside, nuezhenidic acid, oleoside-11-methyl ester, specnuezhenide, 1‴-O-β-d-glucosylformoside, G13, and oleonuezhenide) were determined. Regarding the pharmacodynamics, LLF and WLL extracts decreased the levels of blood glucose, serum creatinine (SCr), blood urea nitrogen (BUN), and 24-h urinary protein (24-h Upro) in DN rats. Furthermore, LLF and WLL extracts increased the level of high-density lipoprotein cholesterol (HDL-C); decreased the levels of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C); and reduced levels of pro-inflammatory cytokines (IL-1β, TNF-α, and IL-6) in DN rats. The anti-diabetic nephropathy effect of the WLL extract was better than that of the LLF extract. Regarding the pharmacokinetic and kidney tissue distribution, there were obvious differences in the eight ingredients between LLF and WLL extracts in DN rats. LLF and WLL extracts had protective effects on DN rats, while the WLL extract was better than the LLF extract regarding anti-diabetic nephropathy effects. The pharmacokinetic parameters and kidney distribution showed that wine-steaming could affect the absorption and distribution of the eight ingredients. The results provided a reasonable basis for the study of the clinical application and processing mechanism of LLF.

Indexed as

Diabetes MellitusDiabetic NephropathiesDrugs, Chinese HerbalLigustrumPlant ExtractsWineAnimalsCholesterolKidneyRatsCholesterolDrugs, Chinese HerbalPlant Extractsdiabetic nephropathy ratskidney distributionLigustri Lucidi Fructus extractpharmacodynamicspharmacokineticswine-steaming

Identifiers

PMID36677849
PMCPMC9867071
OpenAlexW4315853192

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.